Хипертензија (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Хипертензија" in Serbian language version.

refsWebsite

Global rank Serbian rank

81nih.gov

4^th place

8^th place

65doi.org

2^nd place

4^th place

17web.archive.org

1^st place

12archive.org

6^th place

5^th place

12semanticscholar.org

11^th place

23^rd place

9ahajournals.org

3,608^th place

3,815^th place

5archive.today

14^th place

22^nd place

5nice.org.uk

3,258^th place

1,880^th place

2medscape.com

719^th place

468^th place

2who.int

195^th place

154^th place

1vodamagazin.com

low place

1glas-javnosti.co.rs

low place

1chestpubs.org

low place

1harvard.edu

18^th place

28^th place

1wikipedia.org

low place

1handle.net

102^nd place

266^th place

1nps.org.au

low place

1wiley.com

222^nd place

155^th place

1australianprescriber.com

low place

1hta.ac.uk

low place

1webmd.com

1,169^th place

914^th place

1bnf.org

low place

1aafp.org

1,916^th place

2,288^th place

1sagepub.com

731^st place

793^rd place

aafp.org

Luma GB, Spiotta RT (мај 2006). „Hypertension in children and adolescents”. Am Fam Physician. 73 (9): 1558—68. PMID 16719248. Архивирано из оригинала 26. 09. 2007. г. Приступљено 11. 02. 2014.

ahajournals.org

hyper.ahajournals.org

Sorof J, Daniels S (2002). „Obesity hypertension in children: a problem of epidemic proportions”. Hypertension. 40 (4): 441—447. PMID 12364344. doi:10.1161/01.HYP.0000032940.33466.12. Архивирано из оригинала 05. 12. 2012. г. Приступљено 3. 6. 2009.
Chobanian, AV; Bakris, GL; Black, HR; Cushman, WC; Green, LA; Izzo, JL Jr.; Jones, DW; Materson, BJ; Oparil, S; Wright Jr. JT; Roccella EJ (децембар 2003). „Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure”. Hypertension. Joint National Committee On Prevention. 42 (6): 1206—52. PMID 14656957. S2CID 10183942. doi:10.1161/01.HYP.0000107251.49515.c2. Архивирано из оригинала 20. 5. 2012. г. Приступљено 9. 2. 2014.
Go, AS (15. 11. 2013). Bauman, M; King, SM; Fonarow, GC; Lawrence, W; Williams, KA; Sanchez, E.. „An Effective Approach to High Blood Pressure Control: A Science Advisory From the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention.”. Hypertension. PMID 24243703. Архивирано из оригинала 20. 11. 2013. г. Приступљено 11. 2. 2014.
Okonofua, Eni C.; Simpson, Kit N.; Jesri, Ammar; Rehman, Shakaib U.; Durkalski, Valerie L.; Egan, Brent M. (23. 1. 2006). „Therapeutic Inertia Is an Impediment to Achieving the Healthy People 2010 Blood Pressure Control Goals”. Hypertension. 47 (2006;47:345): 345—51. PMID 16432045. doi:10.1161/01.HYP.0000200702.76436.4b. Архивирано из оригинала 29. 6. 2011. г. Приступљено 22. 11. 2009.
Zubcevic J, Waki H, Raizada MK, Paton JF (јун 2011). „Autonomic-immune-vascular interaction: an emerging concept for neurogenic hypertension”. Hypertension. 57 (6): 1026—33. PMC 3105900 . PMID 21536990. doi:10.1161/HYPERTENSIONAHA.111.169748. Архивирано из оригинала 4. 12. 2016. г. Приступљено 11. 2. 2014.
Burt, V. L.; Whelton, P; Roccella, EJ; et al. (март 1995). „Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991”. Hypertension. 25 (3): 305—13. PMID 7875754. doi:10.1161/01.HYP.25.3.305. Архивирано из оригинала 05. 12. 2012. г. Приступљено 5. 6. 2009.
Burt, V. L.; Cutler, JA; Higgins, M; et al. (1995). „Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991”. Hypertension. 26 (1): 60—9. PMID 7607734. Архивирано из оригинала 20. 12. 2012. г. Приступљено 5. 6. 2009.

circ.ahajournals.org

Carretero OA, Oparil S (јануар 2000). „Essential hypertension. Part I: definition and etiology”. Circulation. 101 (3): 329—35. PMID 10645931. doi:10.1161/01.CIR.101.3.329.

stroke.ahajournals.org

Freis, E. D. (1974). „The Veterans Administration Cooperative Study on Antihypertensive Agents. Implications for Stroke Prevention” (PDF). Stroke. 5 (1): 76—77. PMID 4811316. doi:10.1161/01.STR.5.1.76.

archive.org

Fisher ND, Williams GH (2005). „Hypertensive vascular disease”. Ур.: Kasper DL, Braunwald E, Fauci AS. Harrison's Principles of Internal Medicine (16th изд.). New York, NY: McGraw-Hill. стр. 1463-81. ISBN 978-0-07-139140-5.
O'Brien, Eoin; Beevers, D. G.; Lip, Gregory Y. H. (2007). ABC of hypertension. London: BMJ Books. ISBN 978-1-4051-3061-5.
Mesas, A. E.; Leon-Muñoz, L. M.; Rodriguez-Artalejo, F.; Lopez-Garcia, E. (2011). „The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: A systematic review and meta-analysis”. Am J Clin Nutr. 94 (4): 1113—26. PMID 21880846. doi:10.3945/ajcn.111.016667. .
Grossman E, Messerli FH (2012). „Drug-induced Hypertension: An Unappreciated Cause of Secondary Hypertension”. Am. J. Med. 125 (1): 14—22. PMID 22195528. doi:10.1016/j.amjmed.2011.05.024.
Conway, J. (1984). „Hemodynamic aspects of essential hypertension in humans”. Physiol. Rev. 64 (2): 617—60. PMID 6369352.
Safar ME, London GM (1987). „Arterial and venous compliance in sustained essential hypertension”. Hypertension. 10 (2): 133—9. PMID 3301662.
Zieman SJ, Melenovsky V, Kass DA (2005). „Mechanisms, pathophysiology, and therapy of arterial stiffness”. Arterioscler. Thromb. Vasc. Biol. 25 (5): 932—43. PMID 15731494. doi:10.1161/01.ATV.0000160548.78317.29.
Navar, L. G. (2010). „Counterpoint: Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension”. J. Appl. Physiol. 109 (6): 1998—2000; discussion 2015. PMC 3006411 . PMID 21148349. doi:10.1152/japplphysiol.00182.2010a.
Esler M, Lambert E, Schlaich M (2010). „Point: Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension”. J. Appl. Physiol. 109 (6): 1998—8; discussion 2016. PMC 3006411 . PMID 21148349. doi:10.1152/japplphysiol.00182.2010a.
Calhoun, D. A.; Jones, D; Textor, S; et al. (јун 2008). „Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research”. Hypertension. 51 (6): 1403—19. PMID 18391085. doi:10.1161/HYPERTENSIONAHA.108.189141. |first10= захтева |last10= у Authors list (помоћ); |first11= захтева |last11= у Authors list (помоћ)
Ostchega Y, Dillon CF, Hughes JP, Carroll M, Yoon S (јул 2007). „Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004”. Journal of the American Geriatrics Society. 55 (7): 1056—65. PMID 17608879. doi:10.1111/j.1532-5415.2007.01215.x.
Swales, JD, ур. (1995). Manual of hypertension. Oxford: Blackwell Science. стр. xiii. ISBN 978-0-86542-861-4.

archive.today

Marik PE, Varon J (јун 2007). „Hypertensive crises: challenges and management”. Chest. 131 (6): 1949—62. PMID 17565029. doi:10.1378/chest.06-2490. Архивирано из оригинала 04. 12. 2012. г. Приступљено 09. 02. 2014.
Sorof J, Daniels S (2002). „Obesity hypertension in children: a problem of epidemic proportions”. Hypertension. 40 (4): 441—447. PMID 12364344. doi:10.1161/01.HYP.0000032940.33466.12. Архивирано из оригинала 05. 12. 2012. г. Приступљено 3. 6. 2009.
Burt, V. L.; Whelton, P; Roccella, EJ; et al. (март 1995). „Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991”. Hypertension. 25 (3): 305—13. PMID 7875754. doi:10.1161/01.HYP.25.3.305. Архивирано из оригинала 05. 12. 2012. г. Приступљено 5. 6. 2009.
Burt, V. L.; Cutler, JA; Higgins, M; et al. (1995). „Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991”. Hypertension. 26 (1): 60—9. PMID 7607734. Архивирано из оригинала 20. 12. 2012. г. Приступљено 5. 6. 2009.
Alcocer L, Cueto L (2008). „Hypertension, a health economics perspective”. Therapeutic Advances in Cardiovascular Disease. 2 (3): 147—55. PMID 19124418. doi:10.1177/1753944708090572. Архивирано из оригинала 04. 12. 2012. г. Приступљено 20. 6. 2009.

australianprescriber.com

Nelson, Mark. „Drug treatment of elevated blood pressure”. Australian Prescriber (33): 108—112. Архивирано из оригинала 26. 8. 2010. г. Приступљено 11. 8. 2010.

bnf.org

„2.5.5.1 Angiotensin-converting enzyme inhibitors”. British National Formulary. No. 62. септембар 2011. Архивирано из оригинала 23. 12. 2021. г. Приступљено 22. 12. 2011.

chestpubs.org

chestjournal.chestpubs.org

Marik PE, Varon J (јун 2007). „Hypertensive crises: challenges and management”. Chest. 131 (6): 1949—62. PMID 17565029. doi:10.1378/chest.06-2490. Архивирано из оригинала 04. 12. 2012. г. Приступљено 09. 02. 2014.

doi.org

Carretero OA, Oparil S (јануар 2000). „Essential hypertension. Part I: definition and etiology”. Circulation. 101 (3): 329—35. PMID 10645931. doi:10.1161/01.CIR.101.3.329.
Wong T, Mitchell P (фебруар 2007). „The eye in hypertension”. Lancet. 369 (9559): 425—35. PMID 17276782. doi:10.1016/S0140-6736(07)60198-6.
Papadopoulos DP, Mourouzis I, Thomopoulos C, Makris T, Papademetriou V (децембар 2010). „Hypertension crisis”. Blood Press. 19 (6): 328—36. PMID 20504242. doi:10.3109/08037051.2010.488052.
Marik PE, Varon J (јун 2007). „Hypertensive crises: challenges and management”. Chest. 131 (6): 1949—62. PMID 17565029. doi:10.1378/chest.06-2490. Архивирано из оригинала 04. 12. 2012. г. Приступљено 09. 02. 2014.
Dionne JM, Abitbol CL, Flynn JT (јануар 2012). „Hypertension in infancy: diagnosis, management and outcome”. Pediatr. Nephrol. 27 (1): 17—32. PMID 21258818. S2CID 10698052. doi:10.1007/s00467-010-1755-z.
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R (2002). „Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies”. Lancet. 360 (9349): 1903—13. PMID 12493255. doi:10.1016/S0140-6736(02)11911-8.
Singer DR, Kite A (2008). „Management of hypertension in peripheral arterial disease: does the choice of drugs matter?”. European Journal of Vascular and Endovascular Surgery. 35 (6): 701—8. PMID 18375152. doi:10.1016/j.ejvs.2008.01.007.
Zeng C, Villar VA, Yu P, Zhou L, Jose PA (2009). „Reactive oxygen species and dopamine receptor function in essential hypertension”. Clinical and Experimental Hypertension. 31 (2): 156—78. PMID 19330604. doi:10.1080/10641960802621283.
Vasan, RS (27. 2. 2002). Beiser, A, Seshadri, S, Larson, MG, Kannel, WB, D'Agostino, RB, Levy, D.. „Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study.”. JAMA: The Journal of the American Medical Association. 287 (8): 1003—10. PMID 11866648. S2CID 12206390. doi:10.1001/jama.287.8.1003.
International Consortium for Blood Pressure Genome-Wide Association Studies; et al. (2011). „Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk”. Nature. 478 (7367): 103—109. Bibcode:2011Natur.478..103T. PMC 3340926 . PMID 21909115. doi:10.1038/nature10405.
Lifton, RP (23. 2. 2001). Gharavi, AG, Geller, DS. „Molecular mechanisms of human hypertension.”. Cell. 104 (4): 545—56. PMID 11239411. S2CID 9401969. doi:10.1016/s0092-8674(01)00241-0.
He, FJ (јун 2009). MacGregor, GA. „A comprehensive review on salt and health and current experience of worldwide salt reduction programmes.”. Journal of Human Hypertension. 23 (6): 363—84. PMID 19110538. S2CID 4325819. doi:10.1038/jhh.2008.144.
Dickinson, H. O.; Mason, J. M.; Nicolson, D. J.; Campbell, F.; Beyer, F. R.; Cook, J. V.; Williams, B.; Ford, G. A. (2006). „Lifestyle interventions to reduce raised blood pressure: A systematic review of randomized controlled trials”. J Hypertens. 24 (2): 215—33. PMID 16508562. S2CID 9125890. doi:10.1097/01.hjh.0000199800.72563.26. .
Haslam DW, James WP (2005). „Obesity”. Lancet. 366 (9492): 1197—209. PMID 16198769. S2CID 208791491. doi:10.1016/S0140-6736(05)67483-1.
Whelton, P. K.; He, J.; Appel, L. J.; Cutler, J. A.; Havas, S.; Kotchen, TA (2002). „Primary prevention of hypertension: Clinical and public health advisory from The National High Blood Pressure Education Program”. JAMA. 288 (15): 1882—8. PMID 12377087. S2CID 11071351. doi:10.1001/jama.288.15.1882.
Mesas, A. E.; Leon-Muñoz, L. M.; Rodriguez-Artalejo, F.; Lopez-Garcia, E. (2011). „The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: A systematic review and meta-analysis”. Am J Clin Nutr. 94 (4): 1113—26. PMID 21880846. doi:10.3945/ajcn.111.016667. .
Vaidya A, Forman JP (2010). „Vitamin D and hypertension: current evidence and future directions”. Hypertension. 56 (5): 774—9. PMID 20937970. S2CID 25153714. doi:10.1161/HYPERTENSIONAHA.109.140160.
Sorof J, Daniels S (2002). „Obesity hypertension in children: a problem of epidemic proportions”. Hypertension. 40 (4): 441—447. PMID 12364344. doi:10.1161/01.HYP.0000032940.33466.12. Архивирано из оригинала 05. 12. 2012. г. Приступљено 3. 6. 2009.
Lawlor, DA (мај 2005). Smith, GD. „Early life determinants of adult blood pressure.”. Current Opinion in Nephrology and Hypertension. 14 (3): 259—64. PMID 15821420. S2CID 10646150. doi:10.1097/01.mnh.0000165893.13620.2b.
Grossman E, Messerli FH (2012). „Drug-induced Hypertension: An Unappreciated Cause of Secondary Hypertension”. Am. J. Med. 125 (1): 14—22. PMID 22195528. doi:10.1016/j.amjmed.2011.05.024.
Chobanian, A. V. (2007). „Clinical practice Isolated systolic hypertension in the elderly”. New England Journal of Medicine. 357 (8): 789—96. PMID 17715411. doi:10.1056/NEJMcp071137.
Zieman SJ, Melenovsky V, Kass DA (2005). „Mechanisms, pathophysiology, and therapy of arterial stiffness”. Arterioscler. Thromb. Vasc. Biol. 25 (5): 932—43. PMID 15731494. doi:10.1161/01.ATV.0000160548.78317.29.
Navar, L. G. (2010). „Counterpoint: Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension”. J. Appl. Physiol. 109 (6): 1998—2000; discussion 2015. PMC 3006411 . PMID 21148349. doi:10.1152/japplphysiol.00182.2010a.
Esler M, Lambert E, Schlaich M (2010). „Point: Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension”. J. Appl. Physiol. 109 (6): 1998—8; discussion 2016. PMC 3006411 . PMID 21148349. doi:10.1152/japplphysiol.00182.2010a.
Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S (2009). „Endothelium-dependent contractions and endothelial dysfunction in human hypertension”. Br. J. Pharmacol. 157 (4): 527—36. PMC 2707964 . PMID 19630832. doi:10.1111/j.1476-5381.2009.00240.x.
Marchesi C, Paradis P, Schiffrin EL (2008). „Role of the renin-angiotensin system in vascular inflammation”. Trends Pharmacol. Sci. 29 (7): 367—74. PMID 18579222. doi:10.1016/j.tips.2008.05.003.
Padwal, R. J.; Hemmelgarn, BR; Khan, NA; et al. (јун 2008). „The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk”. Canadian Journal of Cardiology. 24 (6): 455—63. PMC 2643189 . PMID 18548142. doi:10.1016/S0828-282X(08)70619-6. |first10= захтева |last10= у Authors list (помоћ); |first11= захтева |last11= у Authors list (помоћ)
Padwal, R. S.; Hemmelgarn, BR; McAlister, FA; et al. (мај 2007). „The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk”. Canadian Journal of Cardiology. 23 (7): 529—38. PMC 2650756 . PMID 17534459. doi:10.1016/S0828-282X(07)70797-3. |first10= захтева |last10= у Authors list (помоћ); |first11= захтева |last11= у Authors list (помоћ)
Hemmelgarn, B. R.; McAlister, FA; Grover, S; et al. (мај 2006). „The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I – Blood pressure measurement, diagnosis and assessment of risk”. Canadian Journal of Cardiology. 22 (7): 573—81. PMC 2560864 . PMID 16755312. doi:10.1016/S0828-282X(06)70279-3. |first10= захтева |last10= у Authors list (помоћ); |first11= захтева |last11= у Authors list (помоћ)
Franklin, SS (фебруар 2012). Wilkinson, IB; McEniery, CM. „Unusual hypertensive phenotypes: what is their significance?”. Hypertension. 59 (2): 173—8. PMID 22184330. doi:10.1161/HYPERTENSIONAHA.111.182956.
Chobanian, AV; Bakris, GL; Black, HR; Cushman, WC; Green, LA; Izzo, JL Jr.; Jones, DW; Materson, BJ; Oparil, S; Wright Jr. JT; Roccella EJ (децембар 2003). „Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure”. Hypertension. Joint National Committee On Prevention. 42 (6): 1206—52. PMID 14656957. S2CID 10183942. doi:10.1161/01.HYP.0000107251.49515.c2. Архивирано из оригинала 20. 5. 2012. г. Приступљено 9. 2. 2014.
Giuseppe, Mancia (јул 2013). „2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)”. European heart journal. 34 (28): 2159—219. PMID 23771844. doi:10.1093/eurheartj/eht151. |first2= захтева |last2= у Authors list (помоћ); |first3= захтева |last3= у Authors list (помоћ); |first4= захтева |last4= у Authors list (помоћ); |first5= захтева |last5= у Authors list (помоћ); |first6= захтева |last6= у Authors list (помоћ); |first7= захтева |last7= у Authors list (помоћ); |first8= захтева |last8= у Authors list (помоћ); |first9= захтева |last9= у Authors list (помоћ); |first10= захтева |last10= у Authors list (помоћ); |first11= захтева |last11= у Authors list (помоћ); |first12= захтева |last12= у Authors list (помоћ); |first13= захтева |last13= у Authors list (помоћ); |first14= захтева |last14= у Authors list (помоћ); |first15= захтева |last15= у Authors list (помоћ); |first16= захтева |last16= у Authors list (помоћ); |first17= захтева |last17= у Authors list (помоћ); |first18= захтева |last18= у Authors list (помоћ); |first19= захтева |last19= у Authors list (помоћ); |first20= захтева |last20= у Authors list (помоћ); |first21= захтева |last21= у Authors list (помоћ); |first22= захтева |last22= у Authors list (помоћ); |first23= захтева |last23= у Authors list (помоћ); |first24= захтева |last24= у Authors list (помоћ); |first25= захтева |last25= у Authors list (помоћ); |first26= захтева |last26= у Authors list (помоћ); |first27= захтева |last27= у Authors list (помоћ); |first28= захтева |last28= у Authors list (помоћ); |first29= захтева |last29= у Authors list (помоћ); |first30= захтева |last30= у Authors list (помоћ)
Mancia, G.; G, De Backer; Dominiczak, A; et al. (септембар 2007). „2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension”. J. Hypertens. 25 (9): 1751—62. PMID 17762635. doi:10.1097/HJH.0b013e3282f0580f. |first10= захтева |last10= у Authors list (помоћ); |first11= захтева |last11= у Authors list (помоћ)
Williams, B (март 2004). Poulter, NR, Brown, MJ, Davis, M, McInnes, GT, Potter, JF, Sever, PS, McG Thom, S, British Hypertension, Society. „Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV”. Journal of Human Hypertension. 18 (3): 139—85. PMID 14973512. S2CID 17394122. doi:10.1038/sj.jhh.1001683.
Din-Dzietham R, Liu Y, Bielo MV, Shamsa F (септембар 2007). „High blood pressure trends in children and adolescents in national surveys, 1963 to 2002”. Circulation. 116 (13): 1488—96. PMID 17846287. S2CID 15179990. doi:10.1161/CIRCULATIONAHA.106.683243.
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (август 2004). „The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents”. Pediatrics. 114 (2 Suppl 4th Report): 555—76. PMID 15286277. doi:10.1542/peds.114.2.S2.555. hdl:2027/uc1.c095473177.
Whelton, P. K.; et al. (2002). „Primary prevention of hypertension. Clinical and public health advisory from the National High Blood Pressure Education Program”. JAMA. 288 (15): 1882—1888. PMID 12377087. doi:10.1001/jama.288.15.1882. |first10= захтева |last10= у Authors list (помоћ); |first11= захтева |last11= у Authors list (помоћ)
Siebenhofer, A (7. 9. 2011). Siebenhofer, Andrea, ур. Jeitler, K, Berghold, A, Waltering, A, Hemkens, LG, Semlitsch, T, Pachler, C, Strametz, R, Horvath, K.. „Long-term effects of weight-reducing diets in hypertensive patients”. Cochrane Database of Systematic Reviews. 9 (9): CD008274. PMID 21901719. doi:10.1002/14651858.CD008274.pub2.
He, FJ (2004). MacGregor, Graham A, ур. MacGregor, GA. „Effect of longer-term modest salt reduction on blood pressure”. Cochrane Database of Systematic Reviews (3): CD004937. PMID 15266549. doi:10.1002/14651858.CD004937. Архивирано из оригинала 15. 7. 2011. г. Приступљено 11. 2. 2014.
Diao, Diana (2012). Wright JM, Cundiff DK, Gueyffier F. „Pharmacotherapy for mild hypertension”. Cochrane Database of Systematic Reviews (8). doi:10.1002/14651858.CD006742.pub2. CD006742.
Arguedas, JA (8. 7. 2009). Arguedas, Jose Agustin, ур. Perez, MI; Wright, JM. „Treatment blood pressure targets for hypertension”. Cochrane Database of Systematic Reviews (3): CD004349. PMID 19588353. doi:10.1002/14651858.CD004349.pub2.
Okonofua, Eni C.; Simpson, Kit N.; Jesri, Ammar; Rehman, Shakaib U.; Durkalski, Valerie L.; Egan, Brent M. (23. 1. 2006). „Therapeutic Inertia Is an Impediment to Achieving the Healthy People 2010 Blood Pressure Control Goals”. Hypertension. 47 (2006;47:345): 345—51. PMID 16432045. doi:10.1161/01.HYP.0000200702.76436.4b. Архивирано из оригинала 29. 6. 2011. г. Приступљено 22. 11. 2009.
Klarenbach, SW (мај 2010). McAlister, FA, Johansen, H, Tu, K, Hazel, M, Walker, R, Zarnke, KB, Campbell, NR, Canadian Hypertension Education, Program. „Identification of factors driving differences in cost effectiveness of first-line pharmacological therapy for uncomplicated hypertension”. The Canadian journal of cardiology. 26 (5): e158—63. PMC 2886561 . PMID 20485695. doi:10.1016/S0828-282X(10)70383-4.
Wright JM, Musini VM (2009). Wright, James M, ур. „First-line drugs for hypertension”. Cochrane Database of Systematic Reviews (3): CD001841. PMID 19588327. doi:10.1002/14651858.CD001841.pub2.
James, PA.; Oparil, S.; Carter, BL.; Cushman, WC.; Dennison-Himmelfarb, C.; Handler, J.; Lackland, DT.; Lefevre, ML.; Mackenzie, TD. (децембар 2013). „2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8).”. JAMA. PMID 24352797. doi:10.1001/jama.2013.284427.
Sever PS, Messerli FH (октобар 2011). „Hypertension management 2011: optimal combination therapy”. European Heart Journal. 32 (20): 2499—506. PMID 21697169. doi:10.1093/eurheartj/ehr177.
Musini VM, Tejani AM, Bassett K, Wright JM (2009). Musini, Vijaya M, ур. „Pharmacotherapy for hypertension in the elderly”. Cochrane Database of Systematic Reviews (4): CD000028. PMID 19821263. doi:10.1002/14651858.CD000028.pub2.
James, Paul A. (18. 12. 2013). Oparil, Suzanne; Carter, Barry L.; Cushman, William C.; Dennison-Himmelfarb, Cheryl; Handler, Joel; Lackland, Daniel T.; LeFevre, Michael L.; MacKenzie, Thomas D.; Ogedegbe, Olugbenga; Smith, Sidney C.; Svetkey, Laura P.; Taler, Sandra J.; Townsend, Raymond R.; Wright, Jackson T.; Narva, Andrew S.; Ortiz, Eduardo. „2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults”. JAMA. doi:10.1001/jama.2013.284427.
Zubcevic J, Waki H, Raizada MK, Paton JF (јун 2011). „Autonomic-immune-vascular interaction: an emerging concept for neurogenic hypertension”. Hypertension. 57 (6): 1026—33. PMC 3105900 . PMID 21536990. doi:10.1161/HYPERTENSIONAHA.111.169748. Архивирано из оригинала 4. 12. 2016. г. Приступљено 11. 2. 2014.
Calhoun, D. A.; Jones, D; Textor, S; et al. (јун 2008). „Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research”. Hypertension. 51 (6): 1403—19. PMID 18391085. doi:10.1161/HYPERTENSIONAHA.108.189141. |first10= захтева |last10= у Authors list (помоћ); |first11= захтева |last11= у Authors list (помоћ)
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J (2005). „Global burden of hypertension: analysis of worldwide data”. The Lancet. 365 (9455): 217—23. PMID 15652604. doi:10.1016/S0140-6736(05)17741-1.
Kearney PM, Whelton M, Reynolds K, Whelton PK, He J (јануар 2004). „Worldwide prevalence of hypertension: a systematic review”. J. Hypertens. 22 (1): 11—9. PMID 15106785. doi:10.1097/00004872-200401000-00003.
Burt, V. L.; Whelton, P; Roccella, EJ; et al. (март 1995). „Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991”. Hypertension. 25 (3): 305—13. PMID 7875754. doi:10.1161/01.HYP.25.3.305. Архивирано из оригинала 05. 12. 2012. г. Приступљено 5. 6. 2009.
Ostchega Y, Dillon CF, Hughes JP, Carroll M, Yoon S (јул 2007). „Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004”. Journal of the American Geriatrics Society. 55 (7): 1056—65. PMID 17608879. doi:10.1111/j.1532-5415.2007.01215.x.
Lloyd-Jones D; Adams, R. J.; Brown, T. M. (2010). „Heart disease and stroke statistics--2010 update: a report from the American Heart Association”. Circulation. 121 (7): e46—e215. PMID 20019324. doi:10.1161/CIRCULATIONAHA.109.192667.
Falkner, B. (мај 2009). „Hypertension in children and adolescents: epidemiology and natural history”. Pediatr. Nephrol. 25 (7): 1219—24. PMC 2874036 . PMID 19421783. doi:10.1007/s00467-009-1200-3.
Kotchen, T. A. (2011). „Historical trends and milestones in hypertension research: a model of the process of translational research”. Hypertension. 58 (4): 522—38. PMID 21859967. doi:10.1161/HYPERTENSIONAHA.111.177766.
Dustan HP, Roccella EJ, Garrison HH (септембар 1996). „Controlling hypertension. A research success story”. Arch. Intern. Med. 156 (17): 1926—35. PMID 8823146. doi:10.1001/archinte.156.17.1926.
Novello FC, Sprague JM (1957). „Benzothiadiazine dioxides as novel diuretics”. J. Am. Chem. Soc. 79 (8): 2028. doi:10.1021/ja01565a079.
Freis, E. D. (1974). „The Veterans Administration Cooperative Study on Antihypertensive Agents. Implications for Stroke Prevention” (PDF). Stroke. 5 (1): 76—77. PMID 4811316. doi:10.1161/01.STR.5.1.76.
Chockalingam, A. (2007). „Impact of World Hypertension Day”. Canadian Journal of Cardiology. 23 (7): 517—9. PMC 2650754 . PMID 17534457. doi:10.1016/S0828-282X(07)70795-X.
Chockalingam, A. (2008). „World Hypertension Day and global awareness”. Canadian Journal of Cardiology. 24 (6): 441—4. PMC 2643187 . PMID 18548140. doi:10.1016/S0828-282X(08)70617-2.
Alcocer L, Cueto L (2008). „Hypertension, a health economics perspective”. Therapeutic Advances in Cardiovascular Disease. 2 (3): 147—55. PMID 19124418. doi:10.1177/1753944708090572. Архивирано из оригинала 04. 12. 2012. г. Приступљено 20. 6. 2009.
Elliott, William J. (2003). „The Economic Impact of Hypertension”. The Journal of Clinical Hypertension. 5 (4): 3—13. PMID 12826765. doi:10.1111/j.1524-6175.2003.02463.x.
Coca, A. (2008). „Economic benefits of treating high-risk hypertension with angiotensin II receptor antagonists (blockers)”. Clinical Drug Investigation. 28 (4): 211—20. PMID 18345711. doi:10.2165/00044011-200828040-00002.

glas-javnosti.co.rs

Глас јавности^{[мртва веза]}, Приступљено 29. 4. 2013.

handle.net

hdl.handle.net

National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (август 2004). „The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents”. Pediatrics. 114 (2 Suppl 4th Report): 555—76. PMID 15286277. doi:10.1542/peds.114.2.S2.555. hdl:2027/uc1.c095473177.

harvard.edu

adsabs.harvard.edu

International Consortium for Blood Pressure Genome-Wide Association Studies; et al. (2011). „Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk”. Nature. 478 (7367): 103—109. Bibcode:2011Natur.478..103T. PMC 3340926 . PMID 21909115. doi:10.1038/nature10405.

hta.ac.uk

Law M, Wald N, Morris J (2003). „Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy” (PDF). Health Technol Assess. 7 (31): 1—94. PMID 14604498. Архивирано из оригинала (PDF) 4. 3. 2011. г. Приступљено 11. 2. 2014.

medscape.com

emedicine.medscape.com

Gibson, Paul (30. 7. 2009). „Hypertension and Pregnancy”. eMedicine Obstetrics and Gynecology. Medscape. Приступљено 16. 6. 2009.
Rodriguez-Cruz, Edwin (6. 4. 2010). „Hypertension”. eMedicine Pediatrics: Cardiac Disease and Critical Care Medicine. Ettinger, Leigh M. Medscape. Приступљено 16. 6. 2009.

nice.org.uk

National Clinical Guideline Centre (август 2011). „7 Diagnosis of Hypertension, 7.5 Link from evidence to recommendations”. Hypertension (NICE CG 127) (PDF). National Institute for Health and Clinical Excellence. стр. 102. Архивирано из оригинала (PDF) 23. 7. 2013. г. Приступљено 22. 12. 2011.
National Clinical Guidance Centre (август 2011). „7 Diagnosis of Hypertension, 7.5 Link from evidence to recommendations”. Hypertension (NICE CG 127) (PDF). National Institute for Health and Clinical Excellence. стр. 102. Архивирано из оригинала (PDF) 23. 7. 2013. г. Приступљено 22. 12. 2011.
„CG34 Hypertension - quick reference guide” (PDF). National Institute for Health and Clinical Excellence. 28. 6. 2006. Архивирано из оригинала (PDF) 13. 03. 2009. г. Приступљено 4. 3. 2009.

guidance.nice.org.uk

North of England Hypertension Guideline Development Group (2004). „Frequency of measurements”. Essential hypertension (NICE CG18). National Institute for Health and Clinical Excellence. стр. 53. Архивирано из оригинала 14. 07. 2012. г. Приступљено 22. 12. 2011.

publications.nice.org.uk

National Institute Clinical Excellence (август 2011). „1.5 Initiating and monitoring antihypertensive drug treatment, including blood pressure targets”. GC127 Hypertension: Clinical management of primary hypertension in adults. Архивирано из оригинала 10. 1. 2012. г. Приступљено 23. 12. 2011.

nih.gov

ncbi.nlm.nih.gov

Carretero OA, Oparil S (јануар 2000). „Essential hypertension. Part I: definition and etiology”. Circulation. 101 (3): 329—35. PMID 10645931. doi:10.1161/01.CIR.101.3.329.
Wong T, Mitchell P (фебруар 2007). „The eye in hypertension”. Lancet. 369 (9559): 425—35. PMID 17276782. doi:10.1016/S0140-6736(07)60198-6.
Papadopoulos DP, Mourouzis I, Thomopoulos C, Makris T, Papademetriou V (децембар 2010). „Hypertension crisis”. Blood Press. 19 (6): 328—36. PMID 20504242. doi:10.3109/08037051.2010.488052.
Marik PE, Varon J (јун 2007). „Hypertensive crises: challenges and management”. Chest. 131 (6): 1949—62. PMID 17565029. doi:10.1378/chest.06-2490. Архивирано из оригинала 04. 12. 2012. г. Приступљено 09. 02. 2014.
Dionne JM, Abitbol CL, Flynn JT (јануар 2012). „Hypertension in infancy: diagnosis, management and outcome”. Pediatr. Nephrol. 27 (1): 17—32. PMID 21258818. S2CID 10698052. doi:10.1007/s00467-010-1755-z.
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R (2002). „Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies”. Lancet. 360 (9349): 1903—13. PMID 12493255. doi:10.1016/S0140-6736(02)11911-8.
Singer DR, Kite A (2008). „Management of hypertension in peripheral arterial disease: does the choice of drugs matter?”. European Journal of Vascular and Endovascular Surgery. 35 (6): 701—8. PMID 18375152. doi:10.1016/j.ejvs.2008.01.007.
Zeng C, Villar VA, Yu P, Zhou L, Jose PA (2009). „Reactive oxygen species and dopamine receptor function in essential hypertension”. Clinical and Experimental Hypertension. 31 (2): 156—78. PMID 19330604. doi:10.1080/10641960802621283.
Vasan, RS (27. 2. 2002). Beiser, A, Seshadri, S, Larson, MG, Kannel, WB, D'Agostino, RB, Levy, D.. „Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study.”. JAMA: The Journal of the American Medical Association. 287 (8): 1003—10. PMID 11866648. S2CID 12206390. doi:10.1001/jama.287.8.1003.
International Consortium for Blood Pressure Genome-Wide Association Studies; et al. (2011). „Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk”. Nature. 478 (7367): 103—109. Bibcode:2011Natur.478..103T. PMC 3340926 . PMID 21909115. doi:10.1038/nature10405.
Lifton, RP (23. 2. 2001). Gharavi, AG, Geller, DS. „Molecular mechanisms of human hypertension.”. Cell. 104 (4): 545—56. PMID 11239411. S2CID 9401969. doi:10.1016/s0092-8674(01)00241-0.
He, FJ (јун 2009). MacGregor, GA. „A comprehensive review on salt and health and current experience of worldwide salt reduction programmes.”. Journal of Human Hypertension. 23 (6): 363—84. PMID 19110538. S2CID 4325819. doi:10.1038/jhh.2008.144.
Dickinson, H. O.; Mason, J. M.; Nicolson, D. J.; Campbell, F.; Beyer, F. R.; Cook, J. V.; Williams, B.; Ford, G. A. (2006). „Lifestyle interventions to reduce raised blood pressure: A systematic review of randomized controlled trials”. J Hypertens. 24 (2): 215—33. PMID 16508562. S2CID 9125890. doi:10.1097/01.hjh.0000199800.72563.26. .
Haslam DW, James WP (2005). „Obesity”. Lancet. 366 (9492): 1197—209. PMID 16198769. S2CID 208791491. doi:10.1016/S0140-6736(05)67483-1.
Whelton, P. K.; He, J.; Appel, L. J.; Cutler, J. A.; Havas, S.; Kotchen, TA (2002). „Primary prevention of hypertension: Clinical and public health advisory from The National High Blood Pressure Education Program”. JAMA. 288 (15): 1882—8. PMID 12377087. S2CID 11071351. doi:10.1001/jama.288.15.1882.
Mesas, A. E.; Leon-Muñoz, L. M.; Rodriguez-Artalejo, F.; Lopez-Garcia, E. (2011). „The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: A systematic review and meta-analysis”. Am J Clin Nutr. 94 (4): 1113—26. PMID 21880846. doi:10.3945/ajcn.111.016667. .
Vaidya A, Forman JP (2010). „Vitamin D and hypertension: current evidence and future directions”. Hypertension. 56 (5): 774—9. PMID 20937970. S2CID 25153714. doi:10.1161/HYPERTENSIONAHA.109.140160.
Sorof J, Daniels S (2002). „Obesity hypertension in children: a problem of epidemic proportions”. Hypertension. 40 (4): 441—447. PMID 12364344. doi:10.1161/01.HYP.0000032940.33466.12. Архивирано из оригинала 05. 12. 2012. г. Приступљено 3. 6. 2009.
Lawlor, DA (мај 2005). Smith, GD. „Early life determinants of adult blood pressure.”. Current Opinion in Nephrology and Hypertension. 14 (3): 259—64. PMID 15821420. S2CID 10646150. doi:10.1097/01.mnh.0000165893.13620.2b.
Grossman E, Messerli FH (2012). „Drug-induced Hypertension: An Unappreciated Cause of Secondary Hypertension”. Am. J. Med. 125 (1): 14—22. PMID 22195528. doi:10.1016/j.amjmed.2011.05.024.
Conway, J. (1984). „Hemodynamic aspects of essential hypertension in humans”. Physiol. Rev. 64 (2): 617—60. PMID 6369352.
Palatini P, Julius S (2009). „The role of cardiac autonomic function in hypertension and cardiovascular disease”. Curr. Hypertens. Rep. 11 (3): 199—205. PMID 19442329.
Andersson OK, Lingman M, Himmelmann A, Sivertsson R, Widgren BR (2004). „Prediction of future hypertension by casual blood pressure or invasive hemodynamics? A 30-year follow-up study”. Blood Press. 13 (6): 350—4. PMID 15771219.
Folkow, B. (1982). „Physiological aspects of primary hypertension”. Physiol. Rev. 62 (2): 347—504. PMID 6461865.
Struijker Boudier HA, le Noble JL, Messing MW, Huijberts MS, le Noble FA, van Essen H (1992). „The microcirculation and hypertension”. J Hypertens Suppl. 10 (7): S147—56. PMID 1291649.
Safar ME, London GM (1987). „Arterial and venous compliance in sustained essential hypertension”. Hypertension. 10 (2): 133—9. PMID 3301662.
Schiffrin, E. L. (1992). „Reactivity of small blood vessels in hypertension: relation with structural changes. State of the art lecture”. Hypertension. 19 (2 Suppl): II1—9. PMID 1735561.
Chobanian, A. V. (2007). „Clinical practice Isolated systolic hypertension in the elderly”. New England Journal of Medicine. 357 (8): 789—96. PMID 17715411. doi:10.1056/NEJMcp071137.
Zieman SJ, Melenovsky V, Kass DA (2005). „Mechanisms, pathophysiology, and therapy of arterial stiffness”. Arterioscler. Thromb. Vasc. Biol. 25 (5): 932—43. PMID 15731494. doi:10.1161/01.ATV.0000160548.78317.29.
Navar, L. G. (2010). „Counterpoint: Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension”. J. Appl. Physiol. 109 (6): 1998—2000; discussion 2015. PMC 3006411 . PMID 21148349. doi:10.1152/japplphysiol.00182.2010a.
Esler M, Lambert E, Schlaich M (2010). „Point: Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension”. J. Appl. Physiol. 109 (6): 1998—8; discussion 2016. PMC 3006411 . PMID 21148349. doi:10.1152/japplphysiol.00182.2010a.
Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S (2009). „Endothelium-dependent contractions and endothelial dysfunction in human hypertension”. Br. J. Pharmacol. 157 (4): 527—36. PMC 2707964 . PMID 19630832. doi:10.1111/j.1476-5381.2009.00240.x.
Marchesi C, Paradis P, Schiffrin EL (2008). „Role of the renin-angiotensin system in vascular inflammation”. Trends Pharmacol. Sci. 29 (7): 367—74. PMID 18579222. doi:10.1016/j.tips.2008.05.003.
Padwal, R. J.; Hemmelgarn, BR; Khan, NA; et al. (јун 2008). „The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk”. Canadian Journal of Cardiology. 24 (6): 455—63. PMC 2643189 . PMID 18548142. doi:10.1016/S0828-282X(08)70619-6. |first10= захтева |last10= у Authors list (помоћ); |first11= захтева |last11= у Authors list (помоћ)
Padwal, R. S.; Hemmelgarn, BR; McAlister, FA; et al. (мај 2007). „The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk”. Canadian Journal of Cardiology. 23 (7): 529—38. PMC 2650756 . PMID 17534459. doi:10.1016/S0828-282X(07)70797-3. |first10= захтева |last10= у Authors list (помоћ); |first11= захтева |last11= у Authors list (помоћ)
Hemmelgarn, B. R.; McAlister, FA; Grover, S; et al. (мај 2006). „The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I – Blood pressure measurement, diagnosis and assessment of risk”. Canadian Journal of Cardiology. 22 (7): 573—81. PMC 2560864 . PMID 16755312. doi:10.1016/S0828-282X(06)70279-3. |first10= захтева |last10= у Authors list (помоћ); |first11= захтева |last11= у Authors list (помоћ)
Hemmelgarn, B. R.; McAllister, FA; Myers, MG; et al. (јун 2005). „The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk”. Canadian Journal of Cardiology. 21 (8): 645—56. PMID 16003448. |first10= захтева |last10= у Authors list (помоћ); |first11= захтева |last11= у Authors list (помоћ)
Franklin, SS (фебруар 2012). Wilkinson, IB; McEniery, CM. „Unusual hypertensive phenotypes: what is their significance?”. Hypertension. 59 (2): 173—8. PMID 22184330. doi:10.1161/HYPERTENSIONAHA.111.182956.
Luma GB, Spiotta RT (мај 2006). „Hypertension in children and adolescents”. Am Fam Physician. 73 (9): 1558—68. PMID 16719248.
Chobanian, AV; Bakris, GL; Black, HR; Cushman, WC; Green, LA; Izzo, JL Jr.; Jones, DW; Materson, BJ; Oparil, S; Wright Jr. JT; Roccella EJ (децембар 2003). „Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure”. Hypertension. Joint National Committee On Prevention. 42 (6): 1206—52. PMID 14656957. S2CID 10183942. doi:10.1161/01.HYP.0000107251.49515.c2. Архивирано из оригинала 20. 5. 2012. г. Приступљено 9. 2. 2014.
Giuseppe, Mancia (јул 2013). „2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)”. European heart journal. 34 (28): 2159—219. PMID 23771844. doi:10.1093/eurheartj/eht151. |first2= захтева |last2= у Authors list (помоћ); |first3= захтева |last3= у Authors list (помоћ); |first4= захтева |last4= у Authors list (помоћ); |first5= захтева |last5= у Authors list (помоћ); |first6= захтева |last6= у Authors list (помоћ); |first7= захтева |last7= у Authors list (помоћ); |first8= захтева |last8= у Authors list (помоћ); |first9= захтева |last9= у Authors list (помоћ); |first10= захтева |last10= у Authors list (помоћ); |first11= захтева |last11= у Authors list (помоћ); |first12= захтева |last12= у Authors list (помоћ); |first13= захтева |last13= у Authors list (помоћ); |first14= захтева |last14= у Authors list (помоћ); |first15= захтева |last15= у Authors list (помоћ); |first16= захтева |last16= у Authors list (помоћ); |first17= захтева |last17= у Authors list (помоћ); |first18= захтева |last18= у Authors list (помоћ); |first19= захтева |last19= у Authors list (помоћ); |first20= захтева |last20= у Authors list (помоћ); |first21= захтева |last21= у Authors list (помоћ); |first22= захтева |last22= у Authors list (помоћ); |first23= захтева |last23= у Authors list (помоћ); |first24= захтева |last24= у Authors list (помоћ); |first25= захтева |last25= у Authors list (помоћ); |first26= захтева |last26= у Authors list (помоћ); |first27= захтева |last27= у Authors list (помоћ); |first28= захтева |last28= у Authors list (помоћ); |first29= захтева |last29= у Authors list (помоћ); |first30= захтева |last30= у Authors list (помоћ)
Mancia, G.; G, De Backer; Dominiczak, A; et al. (септембар 2007). „2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension”. J. Hypertens. 25 (9): 1751—62. PMID 17762635. doi:10.1097/HJH.0b013e3282f0580f. |first10= захтева |last10= у Authors list (помоћ); |first11= захтева |last11= у Authors list (помоћ)
Williams, B (март 2004). Poulter, NR, Brown, MJ, Davis, M, McInnes, GT, Potter, JF, Sever, PS, McG Thom, S, British Hypertension, Society. „Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV”. Journal of Human Hypertension. 18 (3): 139—85. PMID 14973512. S2CID 17394122. doi:10.1038/sj.jhh.1001683.
Din-Dzietham R, Liu Y, Bielo MV, Shamsa F (септембар 2007). „High blood pressure trends in children and adolescents in national surveys, 1963 to 2002”. Circulation. 116 (13): 1488—96. PMID 17846287. S2CID 15179990. doi:10.1161/CIRCULATIONAHA.106.683243.
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (август 2004). „The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents”. Pediatrics. 114 (2 Suppl 4th Report): 555—76. PMID 15286277. doi:10.1542/peds.114.2.S2.555. hdl:2027/uc1.c095473177.
Whelton, P. K.; et al. (2002). „Primary prevention of hypertension. Clinical and public health advisory from the National High Blood Pressure Education Program”. JAMA. 288 (15): 1882—1888. PMID 12377087. doi:10.1001/jama.288.15.1882. |first10= захтева |last10= у Authors list (помоћ); |first11= захтева |last11= у Authors list (помоћ)
Siebenhofer, A (7. 9. 2011). Siebenhofer, Andrea, ур. Jeitler, K, Berghold, A, Waltering, A, Hemkens, LG, Semlitsch, T, Pachler, C, Strametz, R, Horvath, K.. „Long-term effects of weight-reducing diets in hypertensive patients”. Cochrane Database of Systematic Reviews. 9 (9): CD008274. PMID 21901719. doi:10.1002/14651858.CD008274.pub2.
Go, AS (15. 11. 2013). Bauman, M; King, SM; Fonarow, GC; Lawrence, W; Williams, KA; Sanchez, E.. „An Effective Approach to High Blood Pressure Control: A Science Advisory From the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention.”. Hypertension. PMID 24243703. Архивирано из оригинала 20. 11. 2013. г. Приступљено 11. 2. 2014.
Brook, RD (јун 2013). Appel, LJ; Rubenfire, M; Ogedegbe, G; Bisognano, JD; Elliott, WJ; Fuchs, FD; Hughes, JW; Lackland, DT; Staffileno, BA; Townsend, RR; Rajagopalan, S; American Heart Association Professional Education Committee of the Council for High Blood Pressure Research, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention, and Council on Nutrition, Physical, Activity. „Beyond medications and diet: alternative approaches to lowering blood pressure: a scientific statement from the american heart association.”. Hypertension. 61 (6): 1360—83. PMID 23608661.
Ospina, M. B.; Bond, K; Karkhaneh, M; et al. (јун 2007). „Meditation practices for health: state of the research”. Evid Rep Technol Assess (Full Rep) (155): 1—263. PMID 17764203. |first10= захтева |last10= у Authors list (помоћ); |first11= захтева |last11= у Authors list (помоћ)
Greenhalgh J, Dickson R, Dundar Y (октобар 2009). „The effects of biofeedback for the treatment of essential hypertension: a systematic review”. Health Technol Assess. 13 (46): 1—104. PMID 19822104. Архивирано из оригинала 22. 02. 2014. г. Приступљено 11. 02. 2014.
He, FJ (2004). MacGregor, Graham A, ур. MacGregor, GA. „Effect of longer-term modest salt reduction on blood pressure”. Cochrane Database of Systematic Reviews (3): CD004937. PMID 15266549. doi:10.1002/14651858.CD004937. Архивирано из оригинала 15. 7. 2011. г. Приступљено 11. 2. 2014.
Law M, Wald N, Morris J (2003). „Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy” (PDF). Health Technol Assess. 7 (31): 1—94. PMID 14604498. Архивирано из оригинала (PDF) 4. 3. 2011. г. Приступљено 11. 2. 2014.
Arguedas, JA (8. 7. 2009). Arguedas, Jose Agustin, ур. Perez, MI; Wright, JM. „Treatment blood pressure targets for hypertension”. Cochrane Database of Systematic Reviews (3): CD004349. PMID 19588353. doi:10.1002/14651858.CD004349.pub2.
Okonofua, Eni C.; Simpson, Kit N.; Jesri, Ammar; Rehman, Shakaib U.; Durkalski, Valerie L.; Egan, Brent M. (23. 1. 2006). „Therapeutic Inertia Is an Impediment to Achieving the Healthy People 2010 Blood Pressure Control Goals”. Hypertension. 47 (2006;47:345): 345—51. PMID 16432045. doi:10.1161/01.HYP.0000200702.76436.4b. Архивирано из оригинала 29. 6. 2011. г. Приступљено 22. 11. 2009.
Klarenbach, SW (мај 2010). McAlister, FA, Johansen, H, Tu, K, Hazel, M, Walker, R, Zarnke, KB, Campbell, NR, Canadian Hypertension Education, Program. „Identification of factors driving differences in cost effectiveness of first-line pharmacological therapy for uncomplicated hypertension”. The Canadian journal of cardiology. 26 (5): e158—63. PMC 2886561 . PMID 20485695. doi:10.1016/S0828-282X(10)70383-4.
Wright JM, Musini VM (2009). Wright, James M, ур. „First-line drugs for hypertension”. Cochrane Database of Systematic Reviews (3): CD001841. PMID 19588327. doi:10.1002/14651858.CD001841.pub2.
James, PA.; Oparil, S.; Carter, BL.; Cushman, WC.; Dennison-Himmelfarb, C.; Handler, J.; Lackland, DT.; Lefevre, ML.; Mackenzie, TD. (децембар 2013). „2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8).”. JAMA. PMID 24352797. doi:10.1001/jama.2013.284427.
Sever PS, Messerli FH (октобар 2011). „Hypertension management 2011: optimal combination therapy”. European Heart Journal. 32 (20): 2499—506. PMID 21697169. doi:10.1093/eurheartj/ehr177.
Musini VM, Tejani AM, Bassett K, Wright JM (2009). Musini, Vijaya M, ур. „Pharmacotherapy for hypertension in the elderly”. Cochrane Database of Systematic Reviews (4): CD000028. PMID 19821263. doi:10.1002/14651858.CD000028.pub2.
Zubcevic J, Waki H, Raizada MK, Paton JF (јун 2011). „Autonomic-immune-vascular interaction: an emerging concept for neurogenic hypertension”. Hypertension. 57 (6): 1026—33. PMC 3105900 . PMID 21536990. doi:10.1161/HYPERTENSIONAHA.111.169748. Архивирано из оригинала 4. 12. 2016. г. Приступљено 11. 2. 2014.
Calhoun, D. A.; Jones, D; Textor, S; et al. (јун 2008). „Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research”. Hypertension. 51 (6): 1403—19. PMID 18391085. doi:10.1161/HYPERTENSIONAHA.108.189141. |first10= захтева |last10= у Authors list (помоћ); |first11= захтева |last11= у Authors list (помоћ)
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J (2005). „Global burden of hypertension: analysis of worldwide data”. The Lancet. 365 (9455): 217—23. PMID 15652604. doi:10.1016/S0140-6736(05)17741-1.
Kearney PM, Whelton M, Reynolds K, Whelton PK, He J (јануар 2004). „Worldwide prevalence of hypertension: a systematic review”. J. Hypertens. 22 (1): 11—9. PMID 15106785. doi:10.1097/00004872-200401000-00003.
Burt, V. L.; Whelton, P; Roccella, EJ; et al. (март 1995). „Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991”. Hypertension. 25 (3): 305—13. PMID 7875754. doi:10.1161/01.HYP.25.3.305. Архивирано из оригинала 05. 12. 2012. г. Приступљено 5. 6. 2009.
Burt, V. L.; Cutler, JA; Higgins, M; et al. (1995). „Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991”. Hypertension. 26 (1): 60—9. PMID 7607734. Архивирано из оригинала 20. 12. 2012. г. Приступљено 5. 6. 2009.
Ostchega Y, Dillon CF, Hughes JP, Carroll M, Yoon S (јул 2007). „Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004”. Journal of the American Geriatrics Society. 55 (7): 1056—65. PMID 17608879. doi:10.1111/j.1532-5415.2007.01215.x.
Lloyd-Jones D; Adams, R. J.; Brown, T. M. (2010). „Heart disease and stroke statistics--2010 update: a report from the American Heart Association”. Circulation. 121 (7): e46—e215. PMID 20019324. doi:10.1161/CIRCULATIONAHA.109.192667.
Falkner, B. (мај 2009). „Hypertension in children and adolescents: epidemiology and natural history”. Pediatr. Nephrol. 25 (7): 1219—24. PMC 2874036 . PMID 19421783. doi:10.1007/s00467-009-1200-3.
Luma GB, Spiotta RT (мај 2006). „Hypertension in children and adolescents”. Am Fam Physician. 73 (9): 1558—68. PMID 16719248. Архивирано из оригинала 26. 09. 2007. г. Приступљено 11. 02. 2014.
Esunge, P. M. (1991). „From blood pressure to hypertension: the history of research”. J R Soc Med. 84 (10): 621. PMC 1295564 . PMID 1744849.
Kotchen, T. A. (2011). „Historical trends and milestones in hypertension research: a model of the process of translational research”. Hypertension. 58 (4): 522—38. PMID 21859967. doi:10.1161/HYPERTENSIONAHA.111.177766.
Dustan HP, Roccella EJ, Garrison HH (септембар 1996). „Controlling hypertension. A research success story”. Arch. Intern. Med. 156 (17): 1926—35. PMID 8823146. doi:10.1001/archinte.156.17.1926.
Freis, E. D. (1974). „The Veterans Administration Cooperative Study on Antihypertensive Agents. Implications for Stroke Prevention” (PDF). Stroke. 5 (1): 76—77. PMID 4811316. doi:10.1161/01.STR.5.1.76.
Chockalingam, A. (2007). „Impact of World Hypertension Day”. Canadian Journal of Cardiology. 23 (7): 517—9. PMC 2650754 . PMID 17534457. doi:10.1016/S0828-282X(07)70795-X.
Chockalingam, A. (2008). „World Hypertension Day and global awareness”. Canadian Journal of Cardiology. 24 (6): 441—4. PMC 2643187 . PMID 18548140. doi:10.1016/S0828-282X(08)70617-2.
Alcocer L, Cueto L (2008). „Hypertension, a health economics perspective”. Therapeutic Advances in Cardiovascular Disease. 2 (3): 147—55. PMID 19124418. doi:10.1177/1753944708090572. Архивирано из оригинала 04. 12. 2012. г. Приступљено 20. 6. 2009.
Elliott, William J. (2003). „The Economic Impact of Hypertension”. The Journal of Clinical Hypertension. 5 (4): 3—13. PMID 12826765. doi:10.1111/j.1524-6175.2003.02463.x.
Coca, A. (2008). „Economic benefits of treating high-risk hypertension with angiotensin II receptor antagonists (blockers)”. Clinical Drug Investigation. 28 (4): 211—20. PMID 18345711. doi:10.2165/00044011-200828040-00002.

pubmedcentral.nih.gov

Greenhalgh J, Dickson R, Dundar Y (октобар 2009). „The effects of biofeedback for the treatment of essential hypertension: a systematic review”. Health Technol Assess. 13 (46): 1—104. PMID 19822104. Архивирано из оригинала 22. 02. 2014. г. Приступљено 11. 02. 2014.

nhlbi.nih.gov

„Your Guide To Lowering Your Blood Pressure With DASH” (PDF). Приступљено 8. 6. 2009.

nps.org.au

„NPS Prescribing Practice Review 52: Treating hypertension”. NPS Medicines Wise. 1. 9. 2010. Архивирано из оригинала 22. 2. 2011. г. Приступљено 5. 11. 2010.

sagepub.com

tak.sagepub.com

Alcocer L, Cueto L (2008). „Hypertension, a health economics perspective”. Therapeutic Advances in Cardiovascular Disease. 2 (3): 147—55. PMID 19124418. doi:10.1177/1753944708090572. Архивирано из оригинала 04. 12. 2012. г. Приступљено 20. 6. 2009.

semanticscholar.org

api.semanticscholar.org

Dionne JM, Abitbol CL, Flynn JT (јануар 2012). „Hypertension in infancy: diagnosis, management and outcome”. Pediatr. Nephrol. 27 (1): 17—32. PMID 21258818. S2CID 10698052. doi:10.1007/s00467-010-1755-z.
Vasan, RS (27. 2. 2002). Beiser, A, Seshadri, S, Larson, MG, Kannel, WB, D'Agostino, RB, Levy, D.. „Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study.”. JAMA: The Journal of the American Medical Association. 287 (8): 1003—10. PMID 11866648. S2CID 12206390. doi:10.1001/jama.287.8.1003.
Lifton, RP (23. 2. 2001). Gharavi, AG, Geller, DS. „Molecular mechanisms of human hypertension.”. Cell. 104 (4): 545—56. PMID 11239411. S2CID 9401969. doi:10.1016/s0092-8674(01)00241-0.
He, FJ (јун 2009). MacGregor, GA. „A comprehensive review on salt and health and current experience of worldwide salt reduction programmes.”. Journal of Human Hypertension. 23 (6): 363—84. PMID 19110538. S2CID 4325819. doi:10.1038/jhh.2008.144.
Dickinson, H. O.; Mason, J. M.; Nicolson, D. J.; Campbell, F.; Beyer, F. R.; Cook, J. V.; Williams, B.; Ford, G. A. (2006). „Lifestyle interventions to reduce raised blood pressure: A systematic review of randomized controlled trials”. J Hypertens. 24 (2): 215—33. PMID 16508562. S2CID 9125890. doi:10.1097/01.hjh.0000199800.72563.26. .
Haslam DW, James WP (2005). „Obesity”. Lancet. 366 (9492): 1197—209. PMID 16198769. S2CID 208791491. doi:10.1016/S0140-6736(05)67483-1.
Whelton, P. K.; He, J.; Appel, L. J.; Cutler, J. A.; Havas, S.; Kotchen, TA (2002). „Primary prevention of hypertension: Clinical and public health advisory from The National High Blood Pressure Education Program”. JAMA. 288 (15): 1882—8. PMID 12377087. S2CID 11071351. doi:10.1001/jama.288.15.1882.
Vaidya A, Forman JP (2010). „Vitamin D and hypertension: current evidence and future directions”. Hypertension. 56 (5): 774—9. PMID 20937970. S2CID 25153714. doi:10.1161/HYPERTENSIONAHA.109.140160.
Lawlor, DA (мај 2005). Smith, GD. „Early life determinants of adult blood pressure.”. Current Opinion in Nephrology and Hypertension. 14 (3): 259—64. PMID 15821420. S2CID 10646150. doi:10.1097/01.mnh.0000165893.13620.2b.
Chobanian, AV; Bakris, GL; Black, HR; Cushman, WC; Green, LA; Izzo, JL Jr.; Jones, DW; Materson, BJ; Oparil, S; Wright Jr. JT; Roccella EJ (децембар 2003). „Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure”. Hypertension. Joint National Committee On Prevention. 42 (6): 1206—52. PMID 14656957. S2CID 10183942. doi:10.1161/01.HYP.0000107251.49515.c2. Архивирано из оригинала 20. 5. 2012. г. Приступљено 9. 2. 2014.
Williams, B (март 2004). Poulter, NR, Brown, MJ, Davis, M, McInnes, GT, Potter, JF, Sever, PS, McG Thom, S, British Hypertension, Society. „Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV”. Journal of Human Hypertension. 18 (3): 139—85. PMID 14973512. S2CID 17394122. doi:10.1038/sj.jhh.1001683.
Din-Dzietham R, Liu Y, Bielo MV, Shamsa F (септембар 2007). „High blood pressure trends in children and adolescents in national surveys, 1963 to 2002”. Circulation. 116 (13): 1488—96. PMID 17846287. S2CID 15179990. doi:10.1161/CIRCULATIONAHA.106.683243.

vodamagazin.com

Вода магазин Архивирано на сајту Wayback Machine (14. мај 2008), Приступљено 29. 4. 2013.

web.archive.org

Вода магазин Архивирано на сајту Wayback Machine (14. мај 2008), Приступљено 29. 4. 2013.
National Clinical Guideline Centre (август 2011). „7 Diagnosis of Hypertension, 7.5 Link from evidence to recommendations”. Hypertension (NICE CG 127) (PDF). National Institute for Health and Clinical Excellence. стр. 102. Архивирано из оригинала (PDF) 23. 7. 2013. г. Приступљено 22. 12. 2011.
North of England Hypertension Guideline Development Group (2004). „Frequency of measurements”. Essential hypertension (NICE CG18). National Institute for Health and Clinical Excellence. стр. 53. Архивирано из оригинала 14. 07. 2012. г. Приступљено 22. 12. 2011.
Chobanian, AV; Bakris, GL; Black, HR; Cushman, WC; Green, LA; Izzo, JL Jr.; Jones, DW; Materson, BJ; Oparil, S; Wright Jr. JT; Roccella EJ (децембар 2003). „Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure”. Hypertension. Joint National Committee On Prevention. 42 (6): 1206—52. PMID 14656957. S2CID 10183942. doi:10.1161/01.HYP.0000107251.49515.c2. Архивирано из оригинала 20. 5. 2012. г. Приступљено 9. 2. 2014.
National Clinical Guidance Centre (август 2011). „7 Diagnosis of Hypertension, 7.5 Link from evidence to recommendations”. Hypertension (NICE CG 127) (PDF). National Institute for Health and Clinical Excellence. стр. 102. Архивирано из оригинала (PDF) 23. 7. 2013. г. Приступљено 22. 12. 2011.
„NPS Prescribing Practice Review 52: Treating hypertension”. NPS Medicines Wise. 1. 9. 2010. Архивирано из оригинала 22. 2. 2011. г. Приступљено 5. 11. 2010.
Go, AS (15. 11. 2013). Bauman, M; King, SM; Fonarow, GC; Lawrence, W; Williams, KA; Sanchez, E.. „An Effective Approach to High Blood Pressure Control: A Science Advisory From the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention.”. Hypertension. PMID 24243703. Архивирано из оригинала 20. 11. 2013. г. Приступљено 11. 2. 2014.
Greenhalgh J, Dickson R, Dundar Y (октобар 2009). „The effects of biofeedback for the treatment of essential hypertension: a systematic review”. Health Technol Assess. 13 (46): 1—104. PMID 19822104. Архивирано из оригинала 22. 02. 2014. г. Приступљено 11. 02. 2014.
He, FJ (2004). MacGregor, Graham A, ур. MacGregor, GA. „Effect of longer-term modest salt reduction on blood pressure”. Cochrane Database of Systematic Reviews (3): CD004937. PMID 15266549. doi:10.1002/14651858.CD004937. Архивирано из оригинала 15. 7. 2011. г. Приступљено 11. 2. 2014.
Nelson, Mark. „Drug treatment of elevated blood pressure”. Australian Prescriber (33): 108—112. Архивирано из оригинала 26. 8. 2010. г. Приступљено 11. 8. 2010.
Law M, Wald N, Morris J (2003). „Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy” (PDF). Health Technol Assess. 7 (31): 1—94. PMID 14604498. Архивирано из оригинала (PDF) 4. 3. 2011. г. Приступљено 11. 2. 2014.
Okonofua, Eni C.; Simpson, Kit N.; Jesri, Ammar; Rehman, Shakaib U.; Durkalski, Valerie L.; Egan, Brent M. (23. 1. 2006). „Therapeutic Inertia Is an Impediment to Achieving the Healthy People 2010 Blood Pressure Control Goals”. Hypertension. 47 (2006;47:345): 345—51. PMID 16432045. doi:10.1161/01.HYP.0000200702.76436.4b. Архивирано из оригинала 29. 6. 2011. г. Приступљено 22. 11. 2009.
National Institute Clinical Excellence (август 2011). „1.5 Initiating and monitoring antihypertensive drug treatment, including blood pressure targets”. GC127 Hypertension: Clinical management of primary hypertension in adults. Архивирано из оригинала 10. 1. 2012. г. Приступљено 23. 12. 2011.
„2.5.5.1 Angiotensin-converting enzyme inhibitors”. British National Formulary. No. 62. септембар 2011. Архивирано из оригинала 23. 12. 2021. г. Приступљено 22. 12. 2011.
Zubcevic J, Waki H, Raizada MK, Paton JF (јун 2011). „Autonomic-immune-vascular interaction: an emerging concept for neurogenic hypertension”. Hypertension. 57 (6): 1026—33. PMC 3105900 . PMID 21536990. doi:10.1161/HYPERTENSIONAHA.111.169748. Архивирано из оригинала 4. 12. 2016. г. Приступљено 11. 2. 2014.
„CG34 Hypertension - quick reference guide” (PDF). National Institute for Health and Clinical Excellence. 28. 6. 2006. Архивирано из оригинала (PDF) 13. 03. 2009. г. Приступљено 4. 3. 2009.
Luma GB, Spiotta RT (мај 2006). „Hypertension in children and adolescents”. Am Fam Physician. 73 (9): 1558—68. PMID 16719248. Архивирано из оригинала 26. 09. 2007. г. Приступљено 11. 02. 2014.

webmd.com

Shaw, Gina (7. 3. 2009). „Prehypertension: Early-stage High Blood Pressure”. WebMD. Приступљено 3. 7. 2009.

who.int

„Global health risks: mortality and burden of disease attributable to selected major risks.” (PDF). World Health Organization. 2009. Приступљено 10. 2. 2012.
„WHO Disease and injury country estimates”. World Health Organization. 2009. Приступљено 11. 11. 2009.

wikipedia.org

en.wikipedia.org

National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (август 2004). „The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents”. Pediatrics. 114 (2 Suppl 4th Report): 555—76. PMID 15286277. doi:10.1542/peds.114.2.S2.555. hdl:2027/uc1.c095473177.

wiley.com

onlinelibrary.wiley.com

He, FJ (2004). MacGregor, Graham A, ур. MacGregor, GA. „Effect of longer-term modest salt reduction on blood pressure”. Cochrane Database of Systematic Reviews (3): CD004937. PMID 15266549. doi:10.1002/14651858.CD004937. Архивирано из оригинала 15. 7. 2011. г. Приступљено 11. 2. 2014.